Dermata Therapeutics prices $3.5M equity offering

seekingalpha09-17

Late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases - Dermata Therapeutics (NASDAQ:DRMA) announced the sale of 1.91M shares and warrants to purchase shares...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2468496381?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-17 12:54","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2468496381","market":"nz","top_or_hot":-1,"title":"Dermata Therapeutics prices $3.5M equity offering","media":"seekingalpha","content":"<div>\n<p>Late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases - Dermata Therapeutics (NASDAQ:DRMA) announced the sale of 1.91M shares and warrants to purchase shares...</p>\n\n<a href=\"https://seekingalpha.com/news/4150162-dermata-therapeutics-prices-35m-equity-offering\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dermata Therapeutics prices $3.5M equity offering</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDermata Therapeutics prices $3.5M equity offering\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-17 12:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4150162-dermata-therapeutics-prices-35m-equity-offering><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases - Dermata Therapeutics (NASDAQ:DRMA) announced the sale of 1.91M shares and warrants to purchase shares...</p>\n\n<a href=\"https://seekingalpha.com/news/4150162-dermata-therapeutics-prices-35m-equity-offering\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://seekingalpha.com/news/4150162-dermata-therapeutics-prices-35m-equity-offering","article_id":"2468496381","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2468496381","pubTimestamp":1726548888,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases - Dermata Therapeutics announcedthe sale of 1.91M shares and warrants to purchase shares at $1.83 per share.Gross proceeds from the offering are expected to be approximately $3.5M.The closing of the offering is expected to occur on or about September 17, 2024.The company expects to use net proceeds for general corporate purposes.The stock pricedipped 3%on Monday during after-hours of trade.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","DRMA":"Dermata Therapeutics Inc","BK4139":"生物科技","BK4539":"次新股","BK4007":"制药"},"translate_title":"Dermata Therapeutics股票发行定价为350万美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DRMA":1,"LENZ":1},"content_text":"Late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases - Dermata Therapeutics (NASDAQ:DRMA) announced the sale of 1.91M shares and warrants to purchase shares at $1.83 per share.\nGross proceeds from the offering are expected to be approximately $3.5M.\nThe closing of the offering is expected to occur on or about September 17, 2024.\nThe company expects to use net proceeds for general corporate purposes.\nThe stock price dipped 3% on Monday during after-hours of trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2468496381"}